🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

According to TikTok, the service has removed problematic material and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within minutes of entering one group, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Product Information and Costs

Within these groups, messages show dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially serious medical dangers”.